[1] 朱鹏,庞春英,邓廷贤,等. 水牛HSD17B1基因克隆分析及其真核表达载体构建[J].中国畜牧兽医, 2016, 43(3):559-567.
[2] Hai T, Teng F, Guo R, et al. One-step generation of knockout pigs by zygote injection of CRISPR/Cas system[J]. Cell Res, 2014, 24(3):372-375.
[3] Ni W, Qiao J, Hu S, et al. Efficient gene knockout in goats using CRISPR/Cas9 system[J]. PLoS One, 2014, 9(9):e106718.
[4] Mali P, Yang L, Esvelt K, et al. RNA-guided human genome engineering via Cas9[J]. Science, 2013, 339(6121):823-826.
[5] Nagatake M, Takagi Y, Osada H, et al. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers[J]. Cancer Res, 1996, 56(12):2718-2720.
[6] Hahn S A, Bartsch D, Schroers A, et al. Mutations of the DPC4/Smad4 gene in biliary tract carcinoma[J]. Cancer Res, 1998, 58(6):1124-1126.
[7] Saif M W, Karapanagiotou L, Syrigos K, et al. Genetic alterations in pancreatic cancer[J]. World J Gastroenterol, 2007, 13(33):4423-4430.
[8] Zhou Y X, Zhao M, Li D, et al. Cerebellar deficits and hyperactivity in mice lacking Smad4[J]. J Biol Chem, 2003, 278(43):42313-42320.
[9] Guzman A, Zelman-Femiak M, Boergermann J H, et al. SMAD versus non-SMAD signaling is determined by lateral mobility of bone morphogenetic protein (BMP) receptors[J]. J Biol Chem, 2012, 287(47):39492-39504.
[10] Tao S, Sampath K. Alternative splicing of SMADs in differentiation and tissue homeostasis[J]. Dev Growth Differ, 2010, 52(4):335-342.
[11] Prokova V, Mavridou S, Papakosta P, et al. Novel mutations in Smad proteins that inhibit signaling by the transforming growth factor beta in mammalian cells[J]. Biochemistry, 2007, 46(48):13775-13786.
[12] Xu L, Massague J. Nucleocytoplasmic shuttling of signal transducers[J]. Nat Rev Mol Cell Biol, 2004, 5(3):209-219.
[13] 粟小平,肖宁,罗西尔,等. 水牛MBD3基因克隆分析及其真核表达载体的构建[J]. 中国畜牧兽医, 2016, 43(8):1951-1959.
[14] Wan M, Li C, Zhen G, et al. Injury-activated transforming growth factor beta controls mobilization of mesenchymal stem cells for tissue remodeling[J]. Stem Cells, 2012, 30(11):2498-2511.
[15] Chen G, Deng C, Li Y P. TGF-beta and BMP signaling in osteoblast differentiation and bone formation[J]. Int J Biol Sci, 2012,8(2):272-288.
[16] Yang H, Li G, Wu J J, et al. Protein kinase A modulates transforming growth factor-beta signaling through a direct interaction with Smad4 protein[J]. J Biol Chem, 2013,288(12):8737-8749.
[17] Kay B K, Williamson M P, Sudol M. The importance of being proline:The interaction of proline-rich motifs in signaling proteins with their cognate domains[J]. FASEB J, 2000, 14(2):231-241.
[18] Sirard C, de la Pompa J L, Elia A, et al. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo[J]. Genes Dev, 1998, 12(1):107-119.
[19] Zhang X J, He J P, Wen X X, et al. Immunolocalisation and expression of Smad2 and Smad4 proteins in dog testis during postnatal development[J]. Andrologia, 2011, 43(4):254-260.
[20] Zhou Z, Lu J, Dou J, et al. FHL1 and Smad4 synergistically inhibit vascular endothelial growth factor expression[J]. Mol Med Rep, 2013, 7(2):649-653.
[21] Mao X, Debenedittis P, Sun Y, et al. Vascular smooth muscle cell Smad4 gene is important for mouse vascular development[J]. Arterioscler Thromb Vasc Biol, 2012, 32(9):2171-2177.
[22] Xu Y, Li E, Han Y, et al. Differential expression of mRNAs encoding BMP/Smad pathway molecules in antral follicles of high-and low-fecundity Hu sheep[J]. Anim Reprod Sci, 2010, 120(1-4):47-55.
[23] Pangas S A, Li X, Robertson E J, et al. Premature luteinization and cumulus cell defects in ovarian-specific Smad4 knockout mice[J]. Mol Endocrinol, 2006, 20(6):1406-1422.
[24] Li X, Tripurani S K, James R, et al. Minimal fertility defects in mice deficient in oocyte-expressed Smad4[J]. Biol Reprod, 2012, 86(1):1-6.
[25] Miao Z L, Wang Z N, Cheng L Q, et al. Expression of Smad4 during rat ovarian development[J]. Di Yi Jun Yi Da Xue Xue Bao, 2005, 25(2):127-131.
[26] Wen X, He J, Zhang X, et al. Localization of Smad4 in the ovary of the European hedgehog[J]. Acta Histochem, 2011, 113(3):382-386. |